Omalizumab treatment in combination with any other biologics: Is it really a safe duo?

Published in: The Australasian journal of dermatology (2023)

This observational study demonstrated that omalizumab treatment for CSU in combination with any other biological agents for dermatological disorders appeared to be well tolerated without any major safety concerns.

Keyphrases

combination therapy
replacement therapy
smoking cessation